Transcanalicular Diode Laser Assisted Dacryocystorhinostomy in Primary Acquired Nasolacrimal Duct Obstruction: 2-Year Follow Up

Purpose: To evaluate the success rate of 980 nm transcanalicular diode laser-assisted dacryocystorhinostomy (TDL-DCR) in patients with primary acquired nasolacrimal duct obstruction (PANDO) and to consider the time and the reasons of failure

Göz Kapağında Yoğun Molluskum Kontagiosumu Olan Immunokompetan Çocuğun Sadece Fiziksel Boşaltma Yolu ile Tedavisi

Molluscum contagiosum is a common viral skin infection in children with dome-shaped umbilicated nodules. Diagnosis is based on clinical appearance. An eight-year-old child presented to our clinic with multiple molluscum contagiosum nodules on the right lower and upper eyelid and one small papule on the left upper eyelid. Only a couple of lesions were squeezed with expression of cheesy material from the center of the lesions. In the follow-up period, beside resolution of the squeezed lesions, all other lesions disappeared spontaneously and no new lesion was observed in the following one year. This method is costless, neither needs a chemical agent nor results in scarring, so can be the first choice of treatment. (Turk J Ophthalmol 2014; 44:158-60

Treatment of Extensive Eyelid Molluscum Contagiosum with Physical Expression Alone in an Immunocompetent Child

Molluscum contagiosum is a common viral skin infection in children with dome-shaped umbilicated nodules. Diagnosis is based on clinical appearance. An eight-year-old child presented to our clinic with multiple molluscum contagiosum nodules on the right lower and upper eyelid and one small papule on the left upper eyelid. Only a couple of lesions were squeezed with expression of cheesy material from the center of the lesions. In the follow-up period, beside resolution of the squeezed lesions, all other lesions disappeared spontaneously and no new lesion was observed in the following one year. This method is costless, neither needs a chemical agent nor results in scarring, so can be the first choice of treatment. (Turk J Ophthalmol 2014; 44:158-60

CLINICAL EVALUATION OF CIRCULATING CYTOKERATIN 18 AS A BIOMARKER IN COLORECTAL CANCER THERAPY MONITORIZATION

WOS: 00026408950036